Related Articles
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6